2019 CMU-NUS Joint Symposium in Herbal Medicine and New Drug Development

Date: April 25, 2019

The new era of Artificial Intelligence is coming. In the CMU-NUS Joint Symposium, Chancellor Mien-Chie Hung of CMU encouraged the participants to grasp the trend of future technology, apply big data and AI into the research of new drug development to shorten the time and increase the odds of success.

China Medical University and National University of Singapore held the CMU-NUS Joint Symposium in Herbal Medicine and New Drug Development on April 24th, 2019. Professor Fred Wong, Head of NUS Department of Pharmacology, Professor Christina Chai, Head of NUS Department of Pharmacy, and Doctor Edward Chow from Cancer Science Institute of Singapore, participated in the symposium with the invitation from professor Liang-Yo Yang, the Dean of CMU Office of Global Affairs. Over 50 CMU faculties and students enthusiastically engaged in the symposium.

“The best way to promote advances in science and technology is the idea-exchanging between scholars and researchers. This CMU-NUS joint symposium focuses on herbal medicine, new drug development, and new drug development researches facilitated by AI. I hope this symposium not only enhances international academic exchanges and our friendship, but also strengthens our cooperation in scientific research”, said Chancellor Mien-Chie Hung in the opening remarks.

“Since the joint symposium last year, CMU and NUS have both budgeted funding for four cooperative projects. Hopefully, after this joint symposium, there will be more cooperative projects in the field of herbal medicine and new drug development”, said CMU vice president Lu-Hai Wang.

Nine presentations were delivered in the CMU-NUS Joint Symposium in Herbal Medicine and New Drug Development:

  • Hung-Rong Yen (Associate Dean, CMU College of Chinese Medicine):
    Develop New Drug Targeting IL-17 for the Treatment of Psoriasis from Indigo Naturalis

  • Shih-Chieh Hung (Professor, CMU Institute of New Drug Development):
    Human Mesenchymal Stem Cells and its Roles in Therapeutics

  • Hsiang-Wen Lin (Associate Dean, CMU College of Pharmacy):
    An Overview of the Small-Molecule Drug Discovery Program

  • Yuh-Pyng Sher (Associate Professor, CMU Graduate Institute of Biomedical Sciences):
    Targeting Metastatic-associated Pathways for Cancer treatment: the Impact of ADAM9 (A Disintegrin and Metalloproteinase 9)

  • Heng-Hsiung Wu (PhD, CMU Graduate Institute of Biomedical Sciences):
    Targeting the Mechanistical Process of IL-17B/IL-17RB Oncogenic Signaling for Pancreatic Cancer Treatment

  • Min-Tsang Hsieh (PhD, CMU School of Pharmacy):
    New Bis(hydroxymethyl) Alkanoate Curcuminoid Derivatives Exhibit Activity Against Triple-negative Breast Cancer in Vitro and in Vivo

  • Christina CHAI (Head, NUS Department of Pharmacy):
    Drug Discovery and Development Research in NUS Pharmacy

  • Wai-Shiu Fred WONG (Head of NUS Department of Pharmacology):
    Overview of the Drug Discovery & Optimization Platform in NUHS

  • Edward Kai-Hua CHOW (Doctor, Cancer Science Institute of Singapore):
    AI-based Drug Combination Optimisation for Drug Development and Personalised Medicine

Representatives from both universities showed strong interests in each other’s research topics and there were heated discussion after each session. There are some similarities between the researches done by CMU and NUS, but there are also aspects that are complementary. Therefore, establishing cooperation in the field of herbal medicine and new drug development will surely benefit both universities.

Moreover, both universities agreed to combine the research expertise of CMU’s Research Center for Chinese Herbal Medicine, Drug Development Center, and NUS’s Pharmaceutical Innovation & Research Centre. CMU and NUS will both invest more research resources and put efforts in developing anti-inflammatory drugs for asthma and arthritis, apply QPOP to sort out effective herbal medicine that can regulate immune function, and probe into the possible effects of acupuncture on patients with chronic obtrusive pulmonary diseases.

Before the joint symposium, Dean Liang-Yo Yang and Associate Dean Hung-Rong Yen arranged a visit for the three professors from NUS and led them to the Chinese Medicine Department and Chinese Medicine Pharmacy in China Medical University Hospital (CMUH). The NUS professors were very impressed with the trauma treatment, acupuncture treatment, and the pulse and tongue diagnosis assisted by modern instruments. In addition, they highly appreciated the successful integration of Chinese and Western medicine in the health care service provided by CMUH. NUS professors expressed their intention to closely collaborate with CMU and CMUH, appoint CMU professors specialized in integrated medicine to lecture at NUS, to advocate NUS students’ understanding for Chinese herbal medicine.

(Chinese Version.)


2019 CMU-NUS Joint Symposium in Herbal Medicine and New Drug Development
NUS Professors Visiting Chinese Medicine Department and Chinese Medicine Pharmacy in CMUH